Announcements Trials
Browse Landscape

Status

Completed 1550Terminated 528Recruiting 492Unknown 400Active not recruiting 255Withdrawn 142Not yet recruiting 104Suspended 16Enrolling by invitation 5No longer available 3Available 2Approved for marketing 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Expanded_access 3

Sponsor

Cancer Type

Tumor-Agnostic 2Gastrointestinal 1

Conditions

Multiple Myeloma 20Melanoma 16Prostatic Neoplasms 15Neoplasms 15Recurrence 13Carcinoma, Non-Small-Cell Lung 13Leukemia, Myeloid, Acute 12Glioblastoma 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma 8Breast Neoplasms 7Sarcoma 6Neuroblastoma 6Lung Neoplasms 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Leukemia 6Glioma 6Pancreatic Neoplasms 5Lymphoma, Non-Hodgkin 5Lambert-Eaton Myasthenic Syndrome 5Gastrointestinal Stromal Tumors 5Colorectal Neoplasms 5Carcinoma, Hepatocellular 5Triple Negative Breast Neoplasms 4Neuroendocrine Tumors 4Liver Neoplasms 4Hodgkin Disease 4Carcinoma, Renal Cell 4Precancerous Conditions 3Pheochromocytoma 3

Interventions

selitrectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
No longer available × Neoplasm Metastasis × Clear all
NCT03206931 2021-09-16

Expanded Access to Provide Selitrectinib for the Treatment of Cancers With a NTRK Gene Fusion

Bayer

No longer available
Tumor-Agnostic

Neoplasm Metastasis

NCT00701168 2017-08-23

Therasphere® for Treatment of Unresectable Primary Liver Cancer and Metastatic Liver Cancer

Leo W. Jenkins Cancer Center

No longer available
Gastrointestinal

Carcinoma, Hepatocellular, Neoplasm Metastasis

NCT02473653 2017-08-11

Pilot Trial of HER-2/Neu Pulsed DC1 Vaccine for Patients With HER-2 Positive Metastatic Cancer

University of Pennsylvania

No longer available
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡